« Back
Home /
mAb anti-Human PD-L1

mAb anti-Human PD-L1

Item no.	ANOG-MO-L40044R
Manufacturer	Anogen
Amount	0.5mg
Category	Oncology Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Melanoma Sarcoma Mesothelioma Primary Antibodies By Organ Heart & Blood Cancer
Type	Antibody Monoclonal
Clone	15F2
Specific against	other
Host	Mouse
Isotype	IgG1 kappa
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Available
Description	Mouse monoclonal antibody (mAb) to human programmed death- ligand 1 (PD-L1), or mouse mAb to B7H1, or mouse mAb to human CD274.
Target Protein	Human programmed death-ligand 1 (PD-L1), also known as B7H1 or CD274.
Immunogen	Human cell expressed recombinant PD-L1 (Phe19-Arg238) with poly-histidine tag at C-terminus.
Specificity	Reactive with human programmed death- ligand 1 (PD-L1).
Purification	Protein G affinity purified
Species Reactivity	Human, others not tested.
Myeloma	SP2/0
Background	Programmed Death-Ligand 1 (PD-L1), a 40KD transmembrane protein, is a ligand of immune checkpoint protein Programmed Death-1 (PD-1).
Formulation	Lyophilized from a solution in 0.01M PBS, pH 7.0
Reconstitution	Double distilled water is recommended to reconstitute the antibody to 1mg/mL.
Application info	The antibody reacts with recombinant PD-L1 in indirect ELISA.
Research Area	Immunosuppression. Cancer immunotherapy.
Storage	Store at -20C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.5mg

available

Delivery expected until 12/18/2025

Express Delivery: Save 27 days

Compare

Add to wishlist

Get an offer